# Raffles Medical Group (BSL) FY2025 earnings

Results filed 2026-02-23 for the quarter ended 2025-12-31. Source page: https://earnings.opennash.com/companies/raffles-medical/2025-q4/
Press release and documents: https://www.rafflesmedicalgroup.com/investor-relations/results-and-reports/financial-results/
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

Raffles Medical Group marked its 50th year by preparing a healthy longevity centre, a compliant insurance rider and AI adoption, while China and integrated care drive expansion across 14 Asian cities.

Raffles Medical Group grew through higher patient volumes and larger average bills in its hospitals in Singapore and China. Its China business gained from cost efficiency and partnerships with Shanghai's Renji Hospital and Chongqing's First Affiliated Hospital. RafflesHealthinsurance added new contracts and repriced existing ones while managing claims tightly. The group serves more than 2.8 million patients across four hospitals and over 100 clinics.
Management plans to grow services for ageing populations in Singapore and China, expand across the 14 cities where it operates, and look for earnings-accretive assets in Asia Pacific. A physician-led RafflesHealthyLongevityCentre is due in Q1 2026, and the group intends to adopt AI early. The tension is regulatory: Singapore's higher co-payment cap forces a new insurance rider, though management expects little financial impact.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Revenue | S$765.3 million | up 1.8% from a year ago | GAAP |
| PATMI | S$70.6 million | up 13.4% from a year ago | GAAP |
| Diluted EPS | 3.81 cents | up 14.1% from a year ago | GAAP |
| Operating profit | 90.4 | up 9.5% from a year ago | GAAP |
| Operating cash flow | S$101.3 million |  | GAAP |
| Cash and cash equivalents | S$310.8 million |  |  |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Hospital Services revenue | S$357.8 million | up 3.5% year-on-year |
| Healthcare Services revenue | S$285.9 million |  |
| RafflesHealthinsurance revenue | S$185.2 million | up 4.1% |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Dividend | FY2026 | 3.0 cents per share |

## Key takeaways

1. **Longevity centre opens in Q1 2026** RafflesHealthyLongevityCentre is a physician-led, multidisciplinary service offering advanced diagnostics and evidence-based therapies. It extends the group into personalised preventive care.
2. **China hospitals gain from local partnerships** RafflesChinaHealthcare is partnering with Shanghai's Renji Hospital and Chongqing's First Affiliated Hospital. Management says earlier cost efficiency initiatives improved the bottom line and position China for a growing contribution.
3. **Insurance arm adapts to new co-payment cap** The Ministry of Health set a higher co-payment cap of at least S$6,000, and RHI will launch a compliant rider. Management does not expect a significant financial impact.
4. **Integrated care pairs hospitals with insurance** RMG positions itself as an end-to-end provider of healthcare and insurance for individuals and corporates. RHI's growth came from contract repricing and new contracts.
5. **Management targets ageing demographics and AI** The group plans to grow services in demand as Singapore and China age, and to be an early adopter of appropriate AI applications. It is also evaluating earnings-accretive assets in Asia Pacific.

## Questions

**What is Raffles Medical launching in 2026?** The RafflesHealthyLongevityCentre is scheduled to open in Q1 2026 as a physician-led, multidisciplinary preventive care service. RHI will also launch a new rider that complies with Singapore's higher co-payment cap.
**How is the China business performing?** RafflesChinaHealthcare revenue rose 2.3% to CNY359.4 million, helped by cost efficiencies and partnerships with Renji Hospital and Chongqing's First Affiliated Hospital.
**How will Singapore's new co-payment cap affect the insurance business?** MOH introduced a co-payment cap of a minimum of S$6,000, and RHI will launch a compliant rider. Management does not expect a significant impact on RHI's financials.
**What is management's strategy for growth?** It plans to serve ageing populations in Singapore and China, expand services across 14 Asian cities, evaluate earnings-accretive Asia Pacific assets and adopt appropriate AI early.
**What is the group's outlook for FY2026?** Based on current conditions and barring unforeseen circumstances, the Board is optimistic the group will remain profitable in FY2026. No numeric guidance was given.

